Standardized SEC financial data for Cryoport, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001124524 · NASDAQ · Pharmaceutical Preparations.
Ratios for fiscal year 2025, standardized from SEC filings.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $78.7M | $222.6M | $237.3M | $168.7M | $156.8M | $176.2M |
| Cost of revenue | $42.4M | $126.0M | $133.4M | $93.3M | $87.1M | $93.1M |
| Gross profit | $36.3M | $96.6M | $103.9M | $75.3M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $93.3M | $628.8M | $523.3M | $456.8M | $250.6M | $411.2M |
| Inventory | $10.5M | $16.5M | $27.7M | $26.2M | $21.5M | $23.2M |
| Total current assets | $147.2M | $693.5M | $604.2M | $535.1M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$14.9M | $8.1M | -$1.9M | -$757K | -$16.3M | -$8.6M |
| Capital expenditures | $8.9M | $23.9M | $22.1M | $38.8M | $17.3M | $16.4M |
| Free cash flow | -$23.8M | -$15.8M | -$24.0M | -$39.5M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CYRX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CYRX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $69.7M |
| $83.1M |
| R&D expense | $9.5M | $16.8M | $15.7M | $18.0M | $17.7M | $17.0M |
| SG&A expense | $56.9M | $97.6M | $120.1M | $108.3M | $109.8M | $102.8M |
| Operating income | -$30.0M | -$17.8M | -$31.9M | -$100.5M | -$121.7M | -$36.8M |
| EBITDA | -$20.1M | $2.4M | -$9.1M | -$73.0M | -$90.9M | -$9.1M |
| Interest expense | $2.6M | $4.7M | $6.1M | $5.9M | $2.7M | $1.6M |
| Pretax income | -$32.7M | -$273.8M | -$35.1M | -$84.2M | -$104.3M | -$32.2M |
| Income tax | $45K | $1.7M | $2.2M | $345K | $359K | $1.8M |
| Net income | -$75.0M | -$283.7M | -$45.3M | -$107.6M | -$122.8M | $78.3M |
| EPS (diluted) | — | $-6.18 | $-0.93 | $-2.21 | $-2.49 | $1.40 |
Standardized from Cryoport, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
| $341.6M |
| $476.2M |
| Property, plant & equipment | $30.0M | $49.0M | $63.6M | $84.9M | $80.0M | $85.4M |
| Goodwill | $145.3M | $147.0M | $151.1M | $76.4M | $20.6M | $22.4M |
| Total assets | $552.4M | $1.11B | $1.04B | $957.7M | $703.5M | $765.0M |
| Total current liabilities | $35.0M | $42.6M | $40.9M | $45.6M | $64.6M | $219.0M |
| Total liabilities | $169.7M | $471.1M | $482.9M | $468.7M | $301.6M | $262.4M |
| Retained earnings | -$192.0M | -$467.5M | -$542.8M | -$642.4M | -$757.2M | -$688.9M |
| Total equity | $382.7M | $641.8M | $555.8M | $489.0M | $401.9M | $502.6M |
| -$33.6M |
| -$25.0M |
| Investing cash flow | -$382.3M | -$469.3M | -$59.7M | $36.0M | $176.8M | $250.3M |
| Financing cash flow | $385.6M | $564.3M | -$39.2M | -$23.8M | -$161.5M | -$21.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Share repurchases | $0 | $0 | $38.0M | — | — | $10.0M |